ECSP066808A - Solución oftálmica que comprende carboximetilcelulosa de sodio e hidroxipropilmetilcelulosa - Google Patents

Solución oftálmica que comprende carboximetilcelulosa de sodio e hidroxipropilmetilcelulosa

Info

Publication number
ECSP066808A
ECSP066808A EC2006006808A ECSP066808A ECSP066808A EC SP066808 A ECSP066808 A EC SP066808A EC 2006006808 A EC2006006808 A EC 2006006808A EC SP066808 A ECSP066808 A EC SP066808A EC SP066808 A ECSP066808 A EC SP066808A
Authority
EC
Ecuador
Prior art keywords
hydroxypropylmethylcellulose
sodium carboxymethylcellulose
ophthalmic solution
hydrogen peroxide
preservative
Prior art date
Application number
EC2006006808A
Other languages
English (en)
Inventor
Fu-Pao Tsao
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ECSP066808A publication Critical patent/ECSP066808A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/40Peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Se proporcionan una solución oftálmica comprende una fuente de peróxido de hidrógeno en una cantidad suficiente para resultar entre aproximadamente 0.001% y aproximadamente 0.01% en peso de peróxido de hidrógeno estabilizado en dicha formulación como un conservador, uno o más estabilizadores de peróxido de hidrógeno ocularmente compatibles, hidroxipropilmetilcelulosa y carboximetilcelulosa de sodio, así como también composiciones farmacéuticas que comprenden tales soluciones
EC2006006808A 2004-03-17 2006-08-30 Solución oftálmica que comprende carboximetilcelulosa de sodio e hidroxipropilmetilcelulosa ECSP066808A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55388004P 2004-03-17 2004-03-17

Publications (1)

Publication Number Publication Date
ECSP066808A true ECSP066808A (es) 2006-11-16

Family

ID=34962605

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006006808A ECSP066808A (es) 2004-03-17 2006-08-30 Solución oftálmica que comprende carboximetilcelulosa de sodio e hidroxipropilmetilcelulosa

Country Status (15)

Country Link
US (4) US20050244509A1 (es)
EP (1) EP1732511A1 (es)
JP (1) JP2007529458A (es)
KR (1) KR20070005625A (es)
CN (1) CN1933812A (es)
AU (1) AU2005224012B2 (es)
BR (1) BRPI0508858A (es)
CA (1) CA2557795A1 (es)
EC (1) ECSP066808A (es)
IL (1) IL177725A0 (es)
MA (1) MA28507B1 (es)
NO (1) NO20064661L (es)
RU (1) RU2006136092A (es)
TN (1) TNSN06293A1 (es)
WO (1) WO2005089715A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070048388A1 (en) * 2005-08-26 2007-03-01 Fu-Pao Tsao Stabilized and preserved ketotifen ophthalmic compositions
US20070048389A1 (en) * 2005-08-26 2007-03-01 Fu-Pao Tsao Stabilized and preserved ketotifen ophthalmic compositions
JP5275214B2 (ja) * 2006-03-17 2013-08-28 ジョンソン・アンド・ジョンソン・ビジョン・ケア・インコーポレイテッド 酸化に不安定な成分を含む眼科用安定組成物
US20070264226A1 (en) * 2006-05-10 2007-11-15 Karagoezian Hampar L Synergistically enhanced disinfecting solutions
AU2013224663B2 (en) * 2007-08-31 2015-01-15 Alcon Inc. Contact Lens Products
TWI419719B (zh) * 2007-08-31 2013-12-21 Novartis Ag 隱形眼鏡產物
US20090239775A1 (en) * 2008-03-19 2009-09-24 Collins Gary L Ophthalmic solutions displaying improved efficacy
TW201127423A (en) 2009-12-17 2011-08-16 Alcon Res Ltd Ophthalmic solutions with improved disinfection profiles
US20150000936A1 (en) * 2011-12-13 2015-01-01 Schlumberger Technology Corporation Energization of an element with a thermally expandable material
CN111338101B (zh) 2015-12-03 2021-11-19 爱尔康公司 接触镜片包装溶液
US10561593B2 (en) 2015-12-28 2020-02-18 Johnson & Johnson Consumer Inc. Hair growth composition and method
CN107041892B (zh) * 2016-07-12 2021-02-26 合肥九研医药科技开发有限公司 羟丙基甲基纤维素在上消化道黏膜损伤护理上的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880601A (en) * 1985-09-27 1989-11-14 Laboratoires, P.O.S. Hydrogen peroxide disinfecting system for contact lenses
US5607698A (en) * 1988-08-04 1997-03-04 Ciba-Geigy Corporation Method of preserving ophthalmic solution and compositions therefor
US5888493A (en) * 1996-12-05 1999-03-30 Sawaya; Assad S. Ophthalmic aqueous gel formulation and related methods
JP2004509925A (ja) * 2000-09-28 2004-04-02 ノバルティス アクチエンゲゼルシャフト 安定化過酸化水素溶液
AR038299A1 (es) * 2002-01-18 2005-01-12 Novartis Ag Metodos para conservar soluciones oftalmicas y soluciones oftalmicas conservadas.

Also Published As

Publication number Publication date
US20050244509A1 (en) 2005-11-03
US20100143493A1 (en) 2010-06-10
AU2005224012B2 (en) 2009-07-02
US20080096978A1 (en) 2008-04-24
CN1933812A (zh) 2007-03-21
TNSN06293A1 (en) 2007-12-03
BRPI0508858A (pt) 2007-08-28
CA2557795A1 (en) 2005-09-29
WO2005089715A1 (en) 2005-09-29
KR20070005625A (ko) 2007-01-10
EP1732511A1 (en) 2006-12-20
RU2006136092A (ru) 2008-04-27
JP2007529458A (ja) 2007-10-25
IL177725A0 (en) 2006-12-31
US20120220961A1 (en) 2012-08-30
NO20064661L (no) 2006-12-14
AU2005224012A1 (en) 2005-09-29
MA28507B1 (fr) 2007-04-03

Similar Documents

Publication Publication Date Title
ECSP066808A (es) Solución oftálmica que comprende carboximetilcelulosa de sodio e hidroxipropilmetilcelulosa
CL2020000468A1 (es) Uso de una formulación estable que comprende una enzima de reemplazo para la enzima lisosomal (divisional solicitud 201801220)
PE20080374A1 (es) Composiciones farmaceuticas de ropinirol
AR061495A1 (es) Composiciones detergentes
AR094012A1 (es) Composiciones estables con peroxido para el cuidado oral
PE20131324A1 (es) Formulacion subcutanea de anticuerpo anti-her2
ECSP088240A (es) Composición de trazodona para administración una vez por día
MX2010007295A (es) Composiciones acuosas estables de ciclosporina.
PE20141384A1 (es) Composiciones de insulina de accion superrapida
AR027391A1 (es) Composiciones farmaceuticas de toxina botulinica
AR056751A1 (es) Composiciones pesticidamente activas que tienen actividad mejorada
AR052545A1 (es) Suspension no acuosa inyectable
EA200870060A1 (ru) Эмульсия бутилфталида для внутривенного введения и ее применение
AR059113A1 (es) Composicion para administracion topica
MX2010009336A (es) Composiciones farmaceuticas acuosas que contienen complejos de borato-poliol.
AR069792A1 (es) Composicion agroquimica y metodo para preparar la misma
EA201170703A1 (ru) Производные адамантилбензамида
CL2009000985A1 (es) Composicion oftalmica que comprende entre 0,16 y 0,19% p/v de un galactomanano, alrededor de 0,7% p/v de un borato, cis-diol y menos de 5 ppm de concentracion de cationes divalentes; y su uso para lubricar el ojo.
CL2012002815A1 (es) Composicion para el cuidado bucal que comprende uno o mas compuesto de curcumina y una fuente de iones de zinc; correspondiente a 0.02 a 3% en peso de citrato de zinc; y uso de una fuente de iones de zinc para suprimir la degradacion y/o decoloracion del compuesto de curcumina en una composicion ara el cuidado bucal.
MY150082A (en) Trans-clomiphene for metabolic syndrome
WO2007090192A3 (en) Stable one-part aqueous tooth whitening composition
PE20130328A1 (es) Composicion de cereal hidrolizado
MA33384B1 (fr) Sulfonamides hétérocycliques, leurs utilisations et compositions pharmaceutiques les contenant
TW200744617A (en) Agent increasing the production of thioredoxin
ATE273033T1 (de) Stabilisierte ophthalmische wasserstoffperoxidlösung